IBM tops Q2 estimates but software shortfall pressures shares — Neutral
IBM Proactive Investors — July 24, 2025International Business Machines Corp (NYSE:IBM) reported second quarter earnings that beat expectations on the top and bottom lines, but a miss on software revenue saw its shares fall almost 9% in early trade on Thursday. Total revenue of $17 billion, up 8% year-over-year, was ahead of the Street consensus of $16.58 billion.

INVESTOR ALERT: Investigation of Replimune Group, Inc. (REPL) Announced by Holzer & Holzer, LLC — Neutral
REPL GlobeNewsWire — July 24, 2025ATLANTA, July 24, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) complied with federal securities laws. On July 22, 2025, Replimune announced it received a Complete Response Letter (“CRL”) from the FDA regarding the Biologics License Application (“BLA”) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma. In the CRL, the FDA indicated “that the IGNYTE trial is not considered to be an adequate and well-controlled clinical investigation that provides substantial evidence of effectiveness.” Following this news, the price of the Company's stock …

AT&T delivered strong Q2 results, driven by robust broadband subscriber growth, a 19% Y/Y consumer fiber revenue increase, and higher average revenue per user. The telecom lowered its net debt to $6.5B compared to last year, and repurchased $1.0B in shares, enhancing shareholder value and supporting future free cash flow. AT&T's dividend remains very safe, with a coverage ratio near 2.0X (based on FY 2025 estimated FCF), and management reaffirmed its full-year EPS and free cash flow outlook.

Berkshire Hills Bancorp (BHLB) Tops Q2 Earnings and Revenue Estimates — Positive
BHLB Zacks Investment Research — July 24, 2025Berkshire Hills Bancorp (BHLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.55 per share a year ago.

Carnival Corporation (CCL) Hits Fresh High: Is There Still Room to Run? — Positive
CCL Zacks Investment Research — July 24, 2025Carnival (CCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Flex (FLEX) Q1 Earnings and Revenues Beat Estimates — Positive
FLEX Zacks Investment Research — July 24, 2025Flex (FLEX) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.51 per share a year ago.

Jabil, Inc. (JBL) Hits Fresh High: Is There Still Room to Run? — Positive
JBL Zacks Investment Research — July 24, 2025Jabil (JBL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Paypal (PYPL) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures — Positive
PYPL Zacks Investment Research — July 24, 2025Beyond analysts' top-and-bottom-line estimates for Paypal (PYPL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

FirstService (FSV) Q2 Earnings and Revenues Top Estimates — Positive
FSV Zacks Investment Research — July 24, 2025FirstService (FSV) came out with quarterly earnings of $1.71 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.36 per share a year ago.

Ferrari N.V. (RACE) Hits Fresh High: Is There Still Room to Run? — Positive
RACE Zacks Investment Research — July 24, 2025Ferrari (RACE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Ralph Lauren Corporation (RL) Hits Fresh High: Is There Still Room to Run? — Positive
RL Zacks Investment Research — July 24, 2025Ralph Lauren (RL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Berger Montague PC Investigates Potential Securities Law Violations by RxSight, Inc. (NASDAQ: RXST) Following Class Action Filing — Neutral
RXST GlobeNewsWire — July 24, 2025PHILADELPHIA, July 24, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC , a nationally recognized securities litigation law firm, is investigating potential securities law violations involving RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). A class action lawsuit was recently filed on behalf of investors who acquired RxSight securities between November 7, 2024 and July 8, 2025 (the “Class Period”).

Integer (ITGR) came out with quarterly earnings of $1.55 per share, missing the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.3 per share a year ago.

Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS — Positive
MRK Zacks Investment Research — July 24, 2025Beyond analysts' top-and-bottom-line estimates for Merck (MRK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Provident Financial (PFS) Tops Q2 Earnings and Revenue Estimates — Positive
PFS Zacks Investment Research — July 24, 2025Provident Financial (PFS) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.06 per share a year ago.

Wall Street's Insights Into Key Metrics Ahead of UnitedHealth (UNH) Q2 Earnings — Neutral
UNH Zacks Investment Research — July 24, 2025Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

S&T Bancorp (STBA) Q2 Earnings and Revenues Surpass Estimates — Positive
STBA Zacks Investment Research — July 24, 2025S&T Bancorp (STBA) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.89 per share a year ago.

Insights Into Astrazeneca (AZN) Q2: Wall Street Projections for Key Metrics — Neutral
AZN Zacks Investment Research — July 24, 2025Evaluate the expected performance of Astrazeneca (AZN) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

P&G (PG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures — Neutral
PG Zacks Investment Research — July 24, 2025Evaluate the expected performance of P&G (PG) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

What Analyst Projections for Key Metrics Reveal About Commvault (CVLT) Q1 Earnings — Neutral
CVLT Zacks Investment Research — July 24, 2025Evaluate the expected performance of Commvault (CVLT) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
